Information for "Tildrakizumab inside the treatments for moderatetosevere hidradenitis suppurativa"
Basic information
| Display title | Tildrakizumab inside the treatments for moderatetosevere hidradenitis suppurativa |
| Default sort key | Tildrakizumab inside the treatments for moderatetosevere hidradenitis suppurativa |
| Page length (in bytes) | 3,740 |
| Page ID | 1033907 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | 196.242.10.104 (talk) |
| Date of page creation | 13:33, 2 December 2022 |
| Latest editor | 196.242.10.104 (talk) |
| Date of latest edit | 13:33, 2 December 2022 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
